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Abstract  
Background 
Evidence suggests first episode psychosis (FEP) is associated with suicide, and the 
influence of depression on suicidal behaviour in cross sectional studies is clear. 
However the influence of depression during FEP on longer-term mortality is not 
certain. Existing evidence was synthesised to understand the influence of depressive 
symptoms during FEP on subsequent suicidal behaviour.  
 
Methods 
Medline, Embase, PsycINFO, Cochrane Library, Web of Science, OpenGrey, and 
NICE Evidence were searched from inception to Jan 25, 2017. Longitudinal 
observational studies assessing the relationship between depressive symptoms 
during FEP with a measure of s at a specified follow-up time were included. 
Summary estimates were extracted. The Downs and Black Instrument was used to 
appraise study quality. Odds ratio (OR) of suicidal behaviour were calculated using 
random effects meta-analyses. The study protocol was registered with PROSPERO 
(CRD42017055881).  
 
Results 
Of 4210 articles found, 23 fulfilled eligibility criteria. 13 were included in meta-
analysis (n=3002). 428 participants demonstrated suicidal behaviour in the study 
periods. Odds of suicidal behaviour during follow-up were significantly higher 
amongst patients with depressive symptoms during FEP compared to those without 
(OR=1.59, 95% CI 1.14–2.21; I2=50.0%, p=0.02). Meta-regression demonstrated no 
evidence of influence of length of follow-up on results. 
 
Conclusions 
Depressive symptoms during FEP are associated with increased longer-term risk of 
suicidal behaviour. This association should be acknowledged during early 
management planning. Large-scale clinical trials are needed to identify efficacious 
management of depression during FEP. 
 
Key words: 
Depression, First episode psychosis, Schizophrenia, Suicidal risk, Meta-analysis  
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1. Introduction 
First episode psychosis (FEP) describes individuals in the early stages of psychotic 
illness or treatment. FEP is defined by first treatment contact, regardless of duration 
of untreated  psychosis (Breitborde et al., 2009). FEP includes diagnoses such as 
schizophrenia, schizoaffective disorder and delusional disorder (WHO, 1992). Co-
morbid depression is common in FEP (Upthegrove et al., 2010) and whilst 
historically there has been some thought that the presence of mood symptoms in 
‘non- affective’ psychoses such as schizophrenia may be a good prognostic 
indicator, with patients appearing more on a ‘bipolar’ rather than deficit end of a 
psychosis continuum model (Craddock N, Craddock N, O'Donovan MC, Owen MJ.  
The genetics of schizophrenia and bipolar disorder: dissecting psychosis.J Med 
Genet. 2005 Mar;42(3):193-204.), more recent evidence suggests that depression in 
FEP is linked  to poorer long term outcomes (Gardsjord et al., 2016; Upthegrove et 
al., 2010). (Conley et al., 2007) report that those with schizophrenia and depression 
are significantly more likely to relapse, to be a safety concern (violent, arrested, 
victimized), have greater substance-related problems and report poorer functioning, 
family relationships, and medication adherence.  
Co-morbid depression is a significant factor in completed suicide in schizophrenia, 
more so than acting on command hallucinations (Crumlish et al., 2005; Dutta et al., 
2011). Co-morbid depression is related to suicidal behavior in FEP, whether in the 
prodrome, acute or early post psychotic phases (Upthegrove et al., 2010). (Dutta et 
al., 2010) demonstrated that the first 12 months after FEP is a time of highest risk for 
completed suicide, however it is also clear that this risk extends to up to 5 years. In 
populations at high risk of developing psychosis, (Kelleher et al., 2013) show that 
attenuated psychotic experiences were relatively common among young people who 
had a diagnosis of moderate depressive disorder, and that the combination of 
experiences in this sample was significantly associated with suicidal behaviour. 
In order to improve prognosis, optimal clinical management during FEP is key, as it 
is likely later trajectories are set during the early stages of psychosis (Harrison et al., 
2001). Understanding the influence of depressive symptoms during FEP on the later 
risk of suicide could help inform early management, ultimately improving prognosis 
and care as co-morbid depressive symptoms present a modifiable target (Häfner et 
al., 2005). One existing review published in 2013, investigated multiple risk factors 
for deliberate self-harm after first episode psychosis, and found depression had a 
significant role (Challis et al., 2013). Another systematic review investigating risk 
factors associated with suicidal behaviour after FEP, concluded depressive 
symptoms were consistently affiliated (Coentre et al., 2017). However, meta-analysis 
was not performed. Further, the exclusion of studies focusing on depressive 
symptoms during acute psychosis meant the influence of depressive symptoms 
during FEP on long-term suicidal risk was not explored.  Other reviews specifically 
investigating the longitudinal influence of risk factors (including depression) on 
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suicidal behaviour have been non-systematic or narrative in nature (Pompili et al., 
2011; Ventriglio et al., 2016) 
Therefore the aim of this study was to systematically synthesize the existing 
evidence of the influence of depressive symptoms during FEP on future, longer-term 
suicidal behaviors. 
2. Methods 
2.1. Search Strategy 
This systematic review and meta-analysis has been completed in accordance with 
PRISMA (Moher et al., 2009) and MOOSE (Stroup et al., 2000) guidelines. Medline, 
Embase, PsycINFO (using ovid interface), Cochrane Library, Web of Science, 
OpenGrey, and NICE Evidence were searched from inception to Jan 25, 2017. The 
search term “[longitudinal or follow-up or prospective or retrospective or cohort or 
case-control] and [(initial or first or recent onset or early) adj3 (psychosis or psychotic 
or schizo*)] was used for Medline. Search terms were adapted for differences in 
subject headings and proximity operators across databases. Searches were limited 
to humans. The Web of Science search was limited to conference papers and 
psychiatry. No time or language restrictions applied. Reference lists and citation 
histories of included studies were checked. Authors were asked for other recently 
published or ongoing studies.  
Inclusion criteria were a) only longitudinal design (prospective or retrospective); b) 
participants experiencing FEP at baseline, in keeping with International Classification 
of Disease-10 codes F20-29, F30·2, F31·2, F31·5 or F32·3; c) mean age of 
participants between 13–45 years (to help ensure homogeneity of papers); d) a 
measure of depressive symptoms or level of depression during FEP (e.g. using a 
validated scale or diagnostic criteria); e) measure of suicidal behhaviour (as defined 
by deliberate self-harm (DSH), suicide attempts, thoughts, plans and completed 
suicide) at specified follow-up time; and f) descriptive or summary statistics 
associating depressive symptoms or level of depression with suicidal behaviour. For 
meta-analysis eligibility, unadjusted summary estimates were required, including 
measures of variability. No minimum study duration was set.  
Randomised controlled trials (RCTs) were excluded as they did not focus on the 
prognostic value of depressive symptoms, although published sub-studies of RCTs 
were eligible. Conference abstracts were excluded. A detailed list of eligibility criteria 
can be found in the protocol, preregistered with PROSPERO (CRD42017055881). 
One researcher (JM) undertook searches and screened titles, abstracts, and full 
texts. Another researcher (RU) blind checked the final included and excluded study 
list. Conflicts were discussed in reference to eligibility criteria and full text of articles. 
2.2. Data Analysis 
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A standardised data extraction form was developed and piloted on five studies. One 
researcher (JM), not blind to study details, uploaded data into an excel spreadsheet 
(Microsoft 2016). In cases of duplicate data, the study with length of follow-up closest 
to the median follow-up time of included studies was chosen for meta-analysis, to 
help ensure homogeneity, and where follow-up was the same, the report with the 
most participants chosen. Data was extracted on general study details (setting, 
country), inclusion criteria (study design, participant demographics, measure of 
depression and outcome), outcome (summary estimate, variability), and details for 
risk of bias assessment (e.g. representative sample included, confounders).  
Random effects models meta-analysis were used as inherent heterogeneity was 
anticipated. Odds ratio (OR) calculated show the odds of suicidal behaviour during 
follow-up among patients with depressive symptoms at inception of FEP over the 
odds among patients without depressive symptoms. Suicidal behaviour (defined as 
self-inflicted, potentially injurious behaviour, regardless of intent to die (Silverman et 
al., 2007a, b) was chosen as the outcome measure as this was the most frequently 
reported measure of suicidal behaviour, compared to suicidal related ideations and 
communications. As absolute number of events were not available in several 
studies, lnOR were used for calculations. One study reporting hazard ratios (Bakst et 
al., 2010) was included in analysis as hazard ratios were assumed similar to ORs as 
the frequency of the event (suicidal behaviour) is low. Standardised mean 
differences (SMD) were calculated for studies reporting depressive symptoms as a 
continuous variable and converted into InOR under the guidance of the Cochrane 
handbook (Higgins and Green, 2011). Where studies reported median depression 
scores, means and standard deviations (SD) were estimated using the method 
recommended by (Hozo et al., 2005). I2 was calculated to evaluate heterogeneity. 
Analyses were two-tailed, with a significance level of 0.05. 
Small study effect was assessed through visual inspection of funnel plot asymmetry 
and by performing tests described by (Egger et al., 1997) and (Begg and Mazumdar, 
1994). Funnel plots, with observed and imputed studies produced by the trim-and-fill 
method (Duval and Tweedie, 2000), are presented. Pre-specified sub-group analysis 
evaluated the impact of depressive symptom assessment on findings. Further post-
hoc sensitivity analysis excluded studies where assumptions had been made, 
differed in study design, and differed in outcome measure. Meta-regression explored 
the influence of length of follow-up on OR. Review Manager (version 5.3) and 
Comprehensive Meta-analysis (version 3) were used for meta-analytic calculations. 
The Downs and Black instrument (Downs and Black, 1998) was used to assess 
standardised risk of bias (Deeks et al., 2003). Six items specifically relating to RCTs 
were not used. Additionally, if characteristics of those lost to follow-up were not 
described and attrition rate was >20%, then high risk of attrition bias was assumed. 
Quality assessment was performed non-blind to study details. The study protocol 
was preregistered on PROSPERO (CRD42017055881).  
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3. Results  
3.1. Study Retrieval and Selection 
4210 unique papers were identified and 559 full text articles were assessed for 
eligibility (figure 1). 536 were excluded. A list of excluded studies with justification is 
available upon request. No suitable non-english articles were identified for inclusion 
in analysis. References of excluded non-English studies are provided 
(supplementary material 1). 23 articles, reporting on 3878 followed-up participants 
from 17 samples, were included in the qualitative review. Ten articles were excluded 
from meta-analysis as six were duplicate data (Klonsky et al., 2012; Madsen, 2016; 
Madsen, 2012; Nordentoft et al., 2002; Sanchez-Gistau, 2015; Yuen, 2014) and four 
had incomplete data for imputation (Ayesa-Arriola, 2015; Hafner, 1999; Krausz, 
1995).  
The median number of participants recruited per sample was 180 (IQR 112–397). 
The mean age was 25.1 (SD 7.97) and 53.2% were male. Eight samples were with 
inpatients, four with inpatients and outpatients combined, four recruited from early 
intervention services, and in one, the setting was unclear. Articles were published 
between 1990–2016. A summary of each studies’ characteristics is presented in 
table 1.  
3.2. Meta-analysis 
Meta-analysis included 13 studies, with 3002 participants. The mean age was 23.6 
(SD 6.97) and 59.2% were male. The median follow-up time was 24 months (IQR 
12–60 months). Of 3002 participants, 428 were reported to have demonstrated 
suicidal behaviour during the study’s follow-up period.  
Six used standardized measures (e.g. Classification Algorithm for the Determination 
of Suicide Attempt and Suicide, European Parasuide Study Interview Schedule, 
Clinical Global Impression of Severity of Suicidality Scale). Four studies used non-
standardized measures: three used informal interviewing with medical records and 
one used medical records alone. For two studies, the method of assessing suicidal 
behaviour was unclear (Arrasate, 2016; Koreen et al., 1993). The final study 
measured suicide attempt and ideation using the suicidal behaviour score of the 
Calgary Depression Scale for Schizophrenia (CDSS) during the 2 weeks prior to 
follow-up (Barrett, 2015) and was excluded as part of a sensitivity analysis. 
Measures of depressive symptoms or level of depression varied: eight used 
validated symptom scales (e.g. CDSS, Becks Depression Inventory), two used 
subscales of the Positive and Negative Syndrome Scale (PANSS), one used a 
subscale of the Brief Psychiatric Rating Scale (BPRS) and two used diagnostic 
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criteria. In one study, baseline depressive symptoms were assumed in one 
participant who attempted suicide as the timing of their depressive episode was 
unclear (Cohen et al., 1990). 11 studies used prospective cohort designs, one was a 
case-control study (Fedyszyn, 2012) and one was a sub-study of a RCT (Bertelsen, 
2007). See Table 1. 
The odds of suicidal behaviour during follow-up were significantly higher in patients 
with depressive symptoms during FEP compared to those without depressive 
symptoms (OR 1.59, 95% CI 1.14–2.21, p=0.006) (figure 2). The equivalent SMD of 
depressive symptoms between those who did and did not attempt suicide is 0.29, 
95% CI 0.08–0.44. Significant moderate heterogeneity was present (I2=50%, 
p=0.02).  
Meta-regression suggests OR do not vary with different follow-up times (coefficient -
0.08, 95%CI -0.23–0·07, p=0.309). 
3.3. Study Heterogeneity 
Visual inspection of funnel plots revealed no asymmetry (supplementary figure 1), 
and asymmetry was insignificant on Begg’s (p=0·95) and Egger’s test (p=0·88), 
suggesting no small study effect. The trim and fill method generated three missing 
studies. Effect size slightly increased and remained significant with these three 
studies imputed (OR 1.98, 95% CI 1.38–2.85).  
3.4 Subset and sensitivity analysis 
Findings did not substantially change when studies differing in study design or 
outcome measure were excluded during sensitivity analyses (see table 2). OR did 
not significantly differ between studies using different methods to measure 
depressive symptoms (validated scale vs subscale vs diagnostic criteria) (p=0·52).  
However, in sub analysis, studies which dichotomised a continuous measure of 
depressive symptoms produced significantly larger effect sizes (OR 3.32, 95% CI 
2.17–5.08) compared to studies using continuous measures (OR 1.18, 95% CI 0.91–
1.54) (p<0.0001).  
Including only studies using multiple methods to assess suicidal  behaviour 
(Addington, 2004; Bakst et al., 2010; Fedyszyn, 2012; Gonzalez-Pinto, 2007; 
Sanchez-Gistau, 2013; Togay, 2015), which would have a low risk of information 
bias, increased the OR and this remained significant (OR 2.46, 95% CI 1.57–3.86, 
p=<0.0001). 
The relationship between depression and suicidal behaviour is dynamic. In order to 
address this, we performed a sub-group analysis to investigate if the timing of 
baseline depressive symptomology assessment influenced the overall effect size. No 
significant change in effect size was found between studies measuring depressive 
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symptoms at different times (p=0.69) (within days of admission vs. at stabilisation vs. 
unclear timing). 
 
3.5. Bias Assessment 
 Bias assessment for individual studies can be found in the supplementary material. 
The largest source of bias resulted from incomplete follow-up. 13 of 23 articles 
(56.5%) reported attrition rate greater than 20%, and of these only seven reported 
characteristics of those lost to follow-up. Of the remaining 10 articles where attrition 
was less than 20%, only six reported the characteristics of those lost to follow-up, 
making attrition bias difficult to assess in several papers. 
Over 70% of studies (17 of 23) did not report whether outcomes were measured 
blind to depression status, a possible source of detection bias. Additionally, recall 
bias may be present in eight of 23 studies which assessed suicidal behavior through 
direct questioning alone, and record bias in two of 23 studies which used medical 
records alone. Eight of 23 studies assessing suicidal behavioiur using mixed 
methods were deemed low risk of information bias. 18 of 23 articles (78.3%) 
approached a representative FEP sample, however for most (19 of 23 articles, 
82.6%) it was unclear whether a representative FEP sample agreed to take part, 
possibly introducing non-response bias. In all studies, it is unlikely bias was 
introduced through inappropriate statistical analysis.  
4. Discussion 
To our knowledge, this is the first meta-analysis completed to date specifically 
investigating the association of depressive symptoms during FEP with long-term 
suicidal behaviour. The results suggest depressive symptoms during FEP are 
associated with greater odds of later suicidal behaviour, within a median follow-up 
time of 24 months. This review adds to the evidence that depressive symptoms 
during FEP carry poor longer-term prognostic significance. These findings are 
strengthened by sensitivity analyses, whereby findings remained significant.  
Our findings add strength to the evidence of (Sönmez et al., 2016), who found 
persistent depression during the first year of treatment of FEP was associated with 
consistently higher levels of suicidal behaviour across a 10-year follow-up period, 
compared to persistent no depression during the first year. Further, our findings are 
consistent with those of a previous systematic meta-analysis which investigated 
several factors associated with deliberate self-harm (defined as self-injury regardless 
of lethal intent) in early psychosis, which demonstrated depression carries a similar 
risk (Challis et al., 2013). Our results specifically focus on depression during FEP, 
and the risk this may convey for subsequent suicidal behavior, suggesting the early 
focus of treatment is needed. 
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It is speculative to suggest how depression during FEP would convey a longer term 
risk of suicidal behaviour. It is possible that for some individuals, the presence of 
depression in FEP represents an enduring trait, or propensity to further depressive 
episodes and with these further suicidal behaviour. There is also some evidence that 
depression in FEP is associated with a range of poorer outcomes, relapse and 
repeated admission, it may be that the association between depression and future 
suicidal behavior is mediated through the cumulative burden of these additional 
negative events (Conley et al., 2007). We have also demonstrated that depression 
during FEP is associated with greater negative appraisals of loss, shame from the 
diagnosis of psychosis and feelings of entrapment (Upthegrove et al.). Recovery 
from these may not necessarily be co-linear with recovery from positive symptoms or 
depression: indeed some evidence suggests the opposite, that negative illness 
appraisals may need specific and targeted therapy or be subject to a lag in 
improvement (Brunet et al., 2012). These negative appraisals are significantly 
associated with risk of suicide and therefore may be the vehicle through which 
depression leads to longer term risk of suicidal behaviour (Upthegrove, 2016). This 
area warrants further targeted intervention trials to fully understand the direction of 
influence and potential improvement in outcome. 
A clear strength of this review is the broad search strategy, devised with an aim to 
retrieve all longitudinal studies of FEP patients. The meta-regression calculation is 
likely to be adequately powered as the number of covariates to studies included is 
within the limits of expert recommendations (Baker et al., 2009). However, there are 
limitations. The review did not use individual participant data which would offer 
several advantages, such as performing consistent adjusted analyses (Abo-Zaid et 
al., 2012). Revised suicidal behaviour nomenclature ‘self-inflicted potentially injurious 
behaviour’ and stresses the need to clarify patient’s intent to die (no intent, 
undetermined intent, some intent), other research suggests that self-harm regardless 
of intent is significant in subsequent suicide (Hawton et al., 2015; Silverman et al., 
2007a, b). However, studies included in this review used varying definitions of 
specific suicidal behaviour, such as suicide attempt or self-harm, and this may 
impact the reliability of combining studies. We were not able to adjust for potential 
confounders as crude estimate summaries were used and results for suicidal 
behavior may be weakened by sub-group analysis which found studies 
dichotomizing continuous measures of depressive symptoms produced significantly 
larger findings than those using continuous measures. Further, it was not possible to 
investigate the difference in effect size between affective and non-affective 
diagnoses, as studies included both diagnostic groups in their samples. It is possible 
the influence of depressive symptoms on longitudinal suicidal risk differs between 
affective and non-affective diagnoses, and is an area for further exploration. Future 
adequately designed longitudinal studies should also adjust for effects of 
confounders, such as previous suicide attempt and substance abuse.  
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Currently, there are no clear guidelines for the management for depression during 
FEP, although growing evidence demonstrates the safety and effectiveness of 
antidepressants in schizophrenia (Gregory A., 2017; Tiihonen et al., 2015). Cognitive 
behavioural therapy for psychosis has shown to be effective in reducing positive and 
negative symptoms, however depressive symptoms have not been considered as a 
primary outcome in trials (Jauhar et al., 2014). Suicide in psychotic disorders 
remains a significant concern, and the findings of this evidence synthesis adds to 
evidence for the need for effective identification and early treatment of depression 
during FEP to reduce the risk of subsequent suicidal behaviour. 
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Table 1: Characteristics of included studies  
 Population Study type Dates N 
recruit
ed 
N 
follow-
up 
Follow up 
period 
Suicidality measure N 
suicidal 
Measure of 
depressive 
symptoms 
Mean (SD) 
depression 
suicidal 
group 
Mean (SD) 
depression 
non-suicidal 
group 
P value  
Studies measuring suicidality, with depressive symptoms as a continuous variable       
Addington 
et al (2004) 
(ADDING
TON, 
2004) 
(ADDING
TON, 
2004) 
Early 
intervention 
service, 
inpatients and 
outpatients; 
Canada 
Prospective 
cohort 
Dec 96 – 
unknown  
290 238 1 year Suicidal behaviour (suicide or 
parasuicide - deliberate self-harm, 
regardless of suicidal intent); 
regular clinical practice, weekly 
case discussion, regional data from 
emergency department 
7/238 CDSS 4·43 (4·16) 4·17 (3·85) NA 
Arrasate et 
al (2016)  
16–65 years, 
psychiatric 
inpatient unit; 
Spain 
Prospective 
cohort 
Jan 96 – 
Dec 97 
112 82 5 years Suicide attempts (suicide or a self-
destructive act sufficient to require 
medical evaluation and carried out 
with probable suicidal intent); 
unclear how measured 
19/82 HDRS 16·00 (7·57) 19·05 (7·77) NA 
Barrett et al 
(2015)  
18–65 years, 
inpatient and 
outpatient 
services; 
Norway 
Prospective 
cohort 
Oct 02 – 
Feb 11  
207 146 1 year, 
(suicidality 
measured 
during past 
2 weeks) 
Suicidality defined as suicide 
ideation or attempts; CDSS >7 
29/146 G6 on PANSS 4* (range1-6) 3* (range 1-6) <0·001 
Canal-
Rivero et al 
(2016)  
14–54 years, 
public mental 
health service; 
Spain 
Prospective 
cohort 
2003 – 
2005 
65 65 
 
 
 
51 
0 – 6 mo. 
 
 
 
6 – 12 mo. 
Suicide attempts; SCAN interview 14/65 
 
 
 
6/51 
Depression 
factor of 
PANSS 
2·12 (1·32) 
 
 
 
3·00 (1·94) 
2·02 (1·17) 
 
 
 
1·89 (0·99) 
0·89 
 
 
 
0·07 
15 
 
Chang et al 
(2015)  
15–25 years, 
early 
intervention 
program; China 
Retrospective 
cohort 
Jul 01 – 
Aug 03 
700 700 3 years Suicide behaviour (suicide attempts 
and completed suicide); systematic 
medical file review, regularly 
updated by standardised clinical 
assessment forms 
 
Completed suicide; systematic 
medical file review, regularly 
updated by standardised clinical 
assessment forms 
70/700 
 
 
 
7/700 
CGI-BP 
depressive score 
2·30 (1·20) 
 
 
 
NA 
2·30 (1·30) 
 
 
 
NA 
0·83 
 
 
 
NA 
Cohen et al 
(1990)  
18–30 years; 
USA 
Sub-study of 
a randomised 
controlled 
trial 
1978 – 
1986 
112 81 Mean 8·4 
years 
Completed suicide; legal authorities 8/77 
 
 
8/81 
Symptom 
Checklist 90 
Revised 
Depression 
Score 
BPRS 
Anxiety/depress
ion Score 
5·89* 
 
 
2·66* 
3·52* 
 
 
2·22* 
<0·05 
 
 
NS 
González 
Pinto et al 
(2007)  
15–65 years, 
inpatient 
psychiatric 
ward; Spain 
Prospective 
cohort  
Feb 97 – 
Jan 99 
112 83 5 years  Suicidal behaviour (self-destructive 
act sufficient to require medical 
evaluation and carried out with 
suicidal intent, completed suicide); 
direct interview, Spanish National 
Statistical Register, medical and 
forensic records 
12/83 HDRS 
 
No. of 
depressive 
symptoms 
(DSM) 
18·42 (8·68) 
 
2·80 (2·60) 
17·93 (7·98) 
 
1·60 (1·80) 
0·85 
 
0·07 
Häfner et al 
(1999)  
12–59 years, 
inpatient 
facilities; 
Germany 
Prospective 
cohort 
1987 – 
1989 
232 115 5 years Suicide ideation or fairly harmless 
suicidal acts; PSE assessment  
 
Suicide attempt (completed or 
serious attempt); PSE assessment 
37/115 
 
8/115 
Mannheim 
Version of 
Disability 
Assessment 
Schedule, 
depressive 
symptom score 
2·11 
 
2·25 
1·90 (total 
sample) 
 
1·90 (total 
sample) 
NA 
 
NA 
Klonsky et 
al (2012)  
15–60 years, 
inpatient 
facilities; USAa 
Prospective 
cohort 
Sep 89 – 
Dec 95 
628 
 
231 10 years Suicide attempt; DSM-III-R  SCID, 
suicide item on HDRS, reason for 
hospitalisation 
44/231 HDRS 18·3 (7·69) 15·2 (7·85) NA 
Robinson et 
al (2010) 
15–30 years, 
early 
Prospective Apr 93 – 413 282 Mean 7·4 Suicide attempts and completed 61/282 BDI 10·3 (6·9) 8·5 (7·3) 0·068 
16 
 
(ROBINS
ON, 2010) 
(ROBINS
ON, 2010)  
intervention 
service; 
Australiab 
cohort Jul 97  years 
 
suicide; WHO Life Chart Schedule 
 
Sanchez-
Gistau et al 
(2015)  
9–17 years, 
inpatients and 
outpatients 
facilities; Spainc 
Prospective 
cohort 
Mar 03 – 
Nov 05 
110 95 1 year Suicidality, self-destructive act with 
some intent to end life; self-
reported suicide attempt, CGI-SS, 
parents asked, medical records 
reviewed 
31/95 HDRS 21·81 (9·63) 12·24 (3·91) 0·01 
Togay et al 
(2015)  
15–45 years, 
inpatients 
facilities; 
Turkey 
Prospective 
cohort 
1996 –
unknown 
172 138 1 year (at 
least) 
Suicide attempts; follow up 
consultations from patient and 
families, medical records reviewed 
11/138 Depression sub 
scale score of 
BPRS 
7·45 (3·62) 6·47 (2·84) 0·30 
Yuen et al 
(2014)  
14–30 years 
early 
intervention  
service; 
Austrailiab 
Prospective 
cohort 
Apr 89 –
Jan 01 
723 491  20 years Completed suicide; National 
Mortality Database, Coroner’s 
Court Victoria; Victorian Registry 
of Births, Deaths and Marriages  
18/491 BDI 6·1 (5·4) 7·3 (7·1) NA 
Studies measuring suicidality, with depressive symptoms as a categorical variable    Odds ratio+ 95% CI  
Ayesa-
Arriola et al 
(2015)  
15–60 years, 
inpatient and 
outpatient 
facilities; Spain 
Retrospective 
cohort 
2001 – 
2010 
397 397 1 mo. 
before 
admis. – 2 
mo. after 
 
2 mo. – 3 
years 
Suicide behaviour and attempts; 
medical records   
35/397 CDSS, 
dichotomised 
>6 
4·41† 
 
 
2·98† 
1·60-12·18† 
 
 
1·09-8·11† 
0·004 
 
 
0·033 
Bakst et al 
(2010)  
 
 
 
15–60 years, 
inpatient 
facilities; USAa 
 
Prospective 
cohort 
Sep 89 – 
Dec 95 
628 
 
 
 
 
529 
 
 
 
 
2 years (at 
least 6 mo.) 
 
2 years (at 
least 6 mo.) 
 
Suicide attempts; SCID, suicide 
item on HDRS, specifically asking 
of suicide attempts 
 
 
Suicide ideation; SCID, suicide 
item on HDRS, reason for 
hospitalisation 
NA 
 
 
 
 
HDRS, 
dichotomised 
>18 
 
 
2·56  
 
 
 
2·18 
1·38-4·77 
 
 
 
1·57 - 3·04 
<0·01 
 
 
 
<0·01 
17 
 
Bertelsen et 
al (2007)  
 
18–45 years, 
inpatient and 
outpatient 
facilities; 
Denmarkd 
Sub study of 
a randomised 
controlled 
trial  
Jan 98 – 
Dec 00 
 
547 419 1 year Suicide plans; selected questions 
from EPSIS II 
 
Suicide attempts; selected questions 
from EPSIS II 
NA 
 
 
NA 
Fulfil ICD-10 
criteria for 
depression 
1·16 
 
 
1·54 
0·74 – 1·83 
 
 
0·78 – 3·02 
NS 
 
 
NS 
Fedyszyn et 
al (2012)  
15–24 years, , 
early 
intervention 
centre; 
Australia 
Case control Dec 02 – 
Nov 05 
180 174 18 mo.  Suicide attempts; medical files, 
suicide risk assessment checklist 
(completed by clinical staff during 
inpatient admission), data from 
emergency department, incident 
cases rated using CAD-SAS  
72/180 Depressed 
mood and at 
least one other 
(DSM-IV-TR) 
symptom of 
major 
depressive 
episode  
4·23 2·21-8·09 <0·0001 
Koreen et 
al (1993)  
14–40 years, 
inpatient 
facilities; USA 
Prospective 
cohort 
1987 – 
1991 
70 64 5 years Suicide ideation; unclear how 
measured 
 
 
Suicide attempts; unclear how 
measured 
24/64 
 
 
 
2/64 
HDRS, 
dichotomised 
>14, or 
‘syndromal’ 
definition of 
depression as 
defined by RDC 
NA 
 
 
 
1·92‡ 
NA 
 
 
 
00·09 – 42·10‡ 
NA 
 
 
 
NS 
Krausz et al 
(1995)  
14–18 years, 
inpatient 
facilities; 
Germany 
 
 
Prospective 
cohort 
1972 – 
1978 
61 NA Average 
30·5 years 
(at least 11 
years) 
Completed suicide; unclear how 
measured 
 
Suicide attempts; unclear how 
measured 
8 
 
 
22 
Depressive 
traits; unclear 
how measured 
NA NA NA 
Madsen et 
al (2012)  
18–45 years, 
inpatient and 
outpatient 
facilities; 
Denmarkd 
Sub study of 
a randomised 
controlled 
trial  
Jan 98 –
Dec 00 
491 386 1 year  Increasing suicidal tendency; 
selected questions from EPSIS II 
NA Fulfil ICD-10 
criteria for 
depression 
NA: OR 
given for 
increasing 
suicidality.  
  
18 
 
Madsen et 
al (2016)  
18–45 years, 
inpatient and 
outpatient 
facilities; 
Denmarkd 
Sub study of 
a randomised 
controlled 
trial 
Jan 98 – 
Dec 00 
547 332 10 years Suicidal trajectory; selected 
questions from EPSIS II 
NA Fulfil ICD-10 
criteria for 
depression 
NA: OR 
given for 
increasing 
suicidality. 
 
 
Nordentoft 
et al (2002)  
18–45 years, 
inpatient and 
outpatient 
facilities; 
Denmarkd 
Sub study of 
a randomised 
controlled 
trial  
Jan 98 – 
Sept 99 
321 227 1 year 
 
 
Suicide thoughts; selected questions 
from EPSIS II during past week 
 
Suicide plans; selected questions 
from EPSIS II during past week 
 
Suicide attempts; selected questions 
from EPSIS II during past year 
 
NA 
 
 
NA 
 
 
31/275 
Fulfil ICD-10 
criteria for 
depression 
1·77 
 
 
1·92 
 
 
1·79 
0·78-3·18 
 
 
0·73-4·38 
 
 
0·87-4·24 
NS 
 
 
NS 
 
 
NS 
Sanchez-
Gistau et al 
(2013)  
9–17 years, 
inpatient and 
outpatient 
facilities; Spainc 
Prospective 
cohort 
Mar 03 – 
Nov 05 
110 82 2 years Suicide attempts (a potentially self-
injurious behaviour, associated with 
at least some intent to die, as a 
result of the act); CGI-SS, Item 3 
HDRS, parents asked, medical 
records reviewed  
10/82 HDRS, 
dichotomised 
>19 
4·66 1·1 – 19·66 0·03 
 
 
a,b,c,dRefers to studies reporting on the same sample 
*Shows medians not means 
+Odds ratios show odds of suicidality measure among those with depressive symptoms during FEP over those without depressive symptoms during FEP  
✝Only multivariate data available 
‡Assumes both participants who attempted suicide had depressive symptoms during FEP 
Abbreviations: admis, admission; BDI, Beck Depression Inventory; BPRS, Brief Psychiatric Rating scale; CAD-SAS, Classification Algorithm for the Determination of 
Suicide Attempt and Suicide; CDSS, Calgary Depression Scale for Schizophrenia; CGI-BP, Clinical Global Impression Scale for Bipolar Disorder; CGI-SS, Clinical Global 
Impression of Severity of Suicidality Scale; DSM, Diagnostic and Statistical Manual of Mental Disorders; EPSIS, European Parasuicide Study Interview Schedule; HDRS, 
Hamilton Depression Rating Scale; ICD, International Classification of Diseases; MANSA, Manchester Short Assessment of Quality of Life; mo., months; NA, not 
applicable; NS, not significant (when no P value is reported); OR, Odds Ratio; PANSS, Positive and Negative Syndrome Scale; RDC, Research Diagnostic Criteria; SCAN, 
Schedule for Clinical Assessment in Neuropsychiatry; SCID, Structured Clinical Interview for DSM-V; WHO, World Health Organisation. 
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Table 2: Summary of Sensitivity Analyse 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
N studies 
N 
Participants 
 
Odds ratio (95% CI) 
 
P Value  
Fixed effect model 13 3,002 1·57 (1·27 – 1·94) <0·0001 
Exclude study reporting suicidal ideation with attempts 
(Barrett, 2015)  
12 2,856 1·59 (1·11 – 2·29) 0·01 
Exclude study where baseline depressive symptoms assumed 
(Cohen et al., 1990) 
12 2,938 1·58 (1·13 – 2·22) 0·008 
Exclude study reporting hazard ratios (Bakst et al., 2010) 12 2,473 1·50 (1·06 – 2·12) 0·02 
Exclude three studies mentioned above 10 2,263 1·49 (1·00 – 2·23) 0·05 
Include only prospective cohort studies 11 2,409 1·40 (1·03 – 1·90) 0·03 
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Figure 1: Study Selection Process 
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(n = 23) 
Records identified through database 
searching 
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Medline = 3,139 
PsycINFO = 562 
Embase = 2,452 
Cochrane Library = 144 
OpenGrey = 169 
NICE Evidence = 100 
Web of Science = 109 
 
 
Additional records identified through 
other sources 
n =   151 
 
Hand searching reference lists = 103 
Citation Search = 46 
Authors = 2 
Records after duplicates removed 
(n =  4,210) 
Abstracts screened 
(n = 4,210) 
Records excluded 
(n = 3,651) 
Full-text articles assessed 
for eligibility 
(n = 559) 
Full-text articles excluded, with 
reasons 
(n = 536) 
 
 
15 Book/thesis/letters 
12 Reviews 
3 Protocols 
2 Qualitative Studies 
36 Not longitudinal 
5 Ambiguous follow-up time 
37 Do not focus on FEP patients 
118 No suicidality outcome  
255 No specific measure of depression 
at baseline 
53 Baseline depression is not 
associated with outcome 
 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 13) 
Excluded (n=10) 
 
6 duplicate data 
2 no estimate of sample variance 
1 only multivariate information 
available 
1 incomplete data set 
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Figure2: Odds ratio of  subsequent suicidal behaviour among those with vs. without depressive symptoms during FEP
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